Haight; Anthony R
Patent Applications and Registrations
Patent applications and USPTO patent grants for Haight; Anthony R.The latest application filed is for "selective reduction of antibodies".
Company Profile
4.27.29
- Haight; Anthony R - Wadsworth IL
- Haight; Anthony R. - Wadsworth IL
- Haight; Anthony R. - Wasdsworth IL
- Haight; Anthony R. - Park City IL
Patent Activity
| Patent | Date |
|---|---|
| Selective Reduction Of Antibodies App 20210017222 - Haight; Anthony R ; et al. | 2021-01-21 |
| BCL-XL Inhibitory Compounds Having Low Cell Permeability and Antibody Drug Conjugates Including the Same App 20200246460 - Kind Code | 2020-08-06 |
| BCL-XL Inhibitory Compounds and Antibody Drug Conjugates Including the Same App 20200239553 - Ackler; Scott L. ; et al. | 2020-07-30 |
| BCL-XL Inhibitory Compounds Having Low Cell Permeability and Antibody Drug Conjugates Including the Same App 20190142941 - Ackler; Scott L. ; et al. | 2019-05-16 |
| Process for preparing antiviral compounds Grant 9,732,045 - Shekhar , et al. August 15, 2 | 2017-08-15 |
| Phosphine ligands for catalytic reactions Grant 9,669,399 - Shekhar , et al. June 6, 2 | 2017-06-06 |
| BCL-XL Inhibitory Compounds Having Low Cell Permeability and Antibody Drug Conjugates Including the Same App 20160339117 - Ackler; Scott L. ; et al. | 2016-11-24 |
| Process For Preparing Antiviral Compounds App 20160332973 - Shekhar; Shashank ; et al. | 2016-11-17 |
| Phosphine Ligands For Catalytic Reactions App 20160263566 - Shekhar; Shashank ; et al. | 2016-09-15 |
| Process for preparing antiviral compounds Grant 9,434,698 - Shekhar , et al. September 6, 2 | 2016-09-06 |
| Phosphine ligands for catalytic reactions Grant 9,381,508 - Shekhar , et al. July 5, 2 | 2016-07-05 |
| BCL-XL Inhibitory Compounds and Antibody Drug Conjugates Including the Same App 20160158377 - Ackler; Scott L. ; et al. | 2016-06-09 |
| Phosphine ligands for catalytic reactions Grant 9,266,913 - Shekhar , et al. February 23, 2 | 2016-02-23 |
| Process for preparing antiviral compounds Grant 9,255,074 - Shekhar , et al. February 9, 2 | 2016-02-09 |
| Phosphine Ligands For Catalytic Reactions App 20150360215 - Shekhar; Shashank ; et al. | 2015-12-17 |
| Phosphine ligands for catalytic reactions Grant 9,200,021 - Shekhar , et al. December 1, 2 | 2015-12-01 |
| Process For Preparing Antiviral Compounds App 20150191437 - Shekhar; Shashank ; et al. | 2015-07-09 |
| Phosphine Ligands For Catalytic Reactions App 20150152126 - Shekhar; Shashank ; et al. | 2015-06-04 |
| Phosphine ligands for catalytic reactions Grant 8,975,443 - Shekhar , et al. March 10, 2 | 2015-03-10 |
| Phosphine Ligands For Catalytic Reactions App 20140371446 - Shekhar; Shashank ; et al. | 2014-12-18 |
| Process for preparing antiviral compounds Grant 8,895,737 - Shekhar , et al. November 25, 2 | 2014-11-25 |
| Phosphine ligands for catalytic reactions Grant 8,841,487 - Shekhar , et al. September 23, 2 | 2014-09-23 |
| Stabilized lipid formulation of apoptosis promoter Grant 8,728,516 - Catron , et al. May 20, 2 | 2014-05-20 |
| Process For Preparing Antiviral Compounds App 20130224149 - Shekhar; Shashank ; et al. | 2013-08-29 |
| Phosphine Ligands For Catalytic Reactions App 20130217876 - Shekhar; Shashank ; et al. | 2013-08-22 |
| Octahydro-pyrrolo[3,4-B]pyrrole derivatives Grant 8,399,468 - Cowart , et al. March 19, 2 | 2013-03-19 |
| Vitamin D receptor activators and methods of making Grant 8,377,913 - Von Geldern , et al. February 19, 2 | 2013-02-19 |
| Methods for making central nervous system agents that are TRPV1 antagonists Grant 8,232,411 - Lukin , et al. July 31, 2 | 2012-07-31 |
| Phosphine Ligands For Catalytic Reactions App 20120022252 - Shekhar; Shashank ; et al. | 2012-01-26 |
| Process For Preparing Antiviral Compounds App 20120014913 - Shekhar; Shashank ; et al. | 2012-01-19 |
| Methods for Preparing S1P Receptor Agonists and Antagonists App 20110190540 - Shekhar; Shashank ; et al. | 2011-08-04 |
| Formulation For Oral Administration Of Apoptosis Promoter App 20100297194 - Catron; Nathaniel ; et al. | 2010-11-25 |
| Stabilized Lipid Formulation Of Apoptosis Promoter App 20100278905 - Catron; Nathaniel ; et al. | 2010-11-04 |
| Lipid Formulation Of Apoptosis Promoter App 20100280031 - David; Paul ; et al. | 2010-11-04 |
| Octahydro-pyrrolo[3,4-b]pyrrole Derivatives App 20100222358 - Cowart; Marlon D. ; et al. | 2010-09-02 |
| Methods For Making Central Nervous System Agents That Are Trpv1 Antagonists App 20100016611 - Lukin; Kirill A. ; et al. | 2010-01-21 |
| Vitamin D Receptor Activators And Methods Of Making App 20090131379 - Von Geldern; Thomas W. ; et al. | 2009-05-21 |
| Octahydro-pyrrolo[3,4-b]pyrrole Derivatives App 20070232612 - Cowart; Marlon D. ; et al. | 2007-10-04 |
| Arylation method for the functionalization of O-allyl erythromycin derivatives Grant 7,071,314 - Zhang , et al. July 4, 2 | 2006-07-04 |
| Retroviral protease inhibiting compounds Grant 6,667,404 - Kempf , et al. December 23, 2 | 2003-12-23 |
| Retroviral protease inhibiting compounds App 20030195362 - Kempf, Dale J. ; et al. | 2003-10-16 |
| Arylation method for the functionalization of O-allyl erythromycin derivatives App 20030125531 - Zhang, Weijang ; et al. | 2003-07-03 |
| Process for preparing 6-o-substituted erythromycin derivatives Grant 6,437,106 - Stoner , et al. August 20, 2 | 2002-08-20 |
| Benzopyranopyrrole and benzopyranopyridine .alpha.-1 adrenergic compounds Grant 6,046,207 - Meyer , et al. April 4, 2 | 2000-04-04 |
| Retroviral protease inhibiting compounds Grant 6,017,928 - Kempf , et al. January 25, 2 | 2000-01-25 |
| Retroviral protease inhibiting compounds Grant 5,580,984 - Kempf , et al. December 3, 1 | 1996-12-03 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 